Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.55% inched 0.74% higher to $161.30 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +1.30% rising 0.75% to 4,471.37 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.91% rising 1.09% to 35,294.76. This was the stock's third consecutive day of gains. Johnson & Johnson closed $18.62 short of its 52-week high ($179.92), which the company reached on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF -1.28% rose 0.94% to $388.13, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +1.66% remained unchanged, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -1.10% fell 0.43% to $41.49. Trading volume (6.9 M) eclipsed its 50-day average volume of 5.8 M.